Market Overview

TransactRx Appoints Mr. David Rowley to Board of Directors

Share:
CORAL GABLES, Fla.--(BUSINESS WIRE)--

TransactRx, the nation's leading provider of vaccine billing and reimbursement solutions, today announced that it has appointed Mr. David Rowley to its Board of Directors. Mr. Rowley will replace Mr. Tosh Pruno who recently acquired a new venture that has required his full attention.

Mr. Rowley is Managing Director and Partner at Chestnut Hill Partners, an award winning merchant bank facilitating and investing in leveraged buyouts of middle market companies. Prior to Chestnut Hill Partners, Mr. Rowley was the Co-Founder and Partner of Axialmarket, a venture capital backed online marketplace in partnership with a one billion dollar global financial services firm.

Prior to Axialmarket, Mr. Rowley was a Vice President at SRS Capital, a New York-based merchant bank focused on health care services and life sciences. While with SRSCapital, Mr. Rowley originated and arranged more than $500 million dollars of equity and debt financing on a broad range of middle market transactions. Mr. Rowley has been published in Mergers & Acquisitions magazine, moderated private equity panel discussions at major industry conferences and currently serves on the boards of DreamTiger Equities and BIDaWIZ.com.

“I am very excited about the addition of Mr. Rowley to our Board,” said Richard A. Wolpow, Founder and Chairman of TransactRx. “I have worked with Mr. Rowley for quite a while, and am confident that his expertise and insights will be of tremendous value to our Company. He brings to TransactRx not only a strong entrepreneurial background but also a solid reputation and experience in the investment banking community.” Mr. Wolpow continues to state, “The timing is ideal for adding Mr. Rowley to our Board; with the launch of our new solutions, current growth rate and capital raise, his relationships and experience will significantly help TransactRx achieve our established goals.”

“I am honored to join Mr. Wolpow and his team as a new Board member of TransactRx,” said Mr. Rowley. “I admire and respect the success and values of this company and its leadership, and am pleased to be able to share my experience as a Board member.”

ABOUT TRANSACTRX

POC Network Technologies, Inc. d.b.a. TransactRx is a leading national provider of reimbursement solutions for vaccines and specialty pharmaceutical products administered at the point-of-care. The TransactRx proprietary technology platform seamlessly connects the nation's pharmacy and medical transaction infrastructures to enable physicians, public health departments and pharmacies to check coverage information and submit claims for both medical and pharmacy benefits. The Company's unique national provider networks significantly reduce the cost and effort associated with contracting a large numbers of providers to administer a particular vaccine or group of pharmaceutical products. The combination of technology and provider networks assists payers of all types including Medicare, Medicaid, Commercial and Employer plans to increase access to vaccines for their members and increase immunization rates.

TransactRx
Andrea Seratte, 800-971-3890
Executive Vice President
aseratte@transactrx.com


View Comments and Join the Discussion!